Similarly, the GNB2 mutation identified in one CM patient is predicted to disrupt a salt bridge bond between the Gα and the Gβγ subunits, impairing GTP hydrolysis and promoting a constitutive Gαq signaling pathway (27). The gene discussed is GNAQ; the disease is cutaneous mastocytosis.